Intervention

Salbutamol

ClinicalTrials.gov intervention label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 39 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials39

Recruiting1

Common conditions25

Lead sponsors shown15

Clinical trials

39 shown

Effects of Salbutamol in Athletes and Implications for Screening and SportsNCT07037511 · 2025-10-30

Open-label Study to Assess Reduction of Background Asthma Medication While Sustaining Asthma Control and Clinical Remission With Tezepelumab in Patients 12-80yrs With Severe Asthma.NCT06473779 · 2024-09-30

ACTIVE_NOT_RECRUITING

CIVETTA: Correlating Inflammatory Values of FEno, SympToms, SpuTum and Lung Function in AsthmaNCT06482294 · 2024-06-18

The Regulatory Function of Inhaled Asthma Medication Salbutamol on ThermogenesisNCT06319183 · 2024-03-01

Role of Parasympathetic Activity in Mild to Severe Asthma With Fixed Airway Obstruction (PARASMA Study)NCT05550402 · 2024-02-17

The Effect of Nebulized Epinephrine in Asthma Exacerbation in Pediatric Age Group With the Standard Treatment Compared to Standard Treatment Using Improvement PRAM Score as a Primary OutcomeNCT05667727 · 2023-10-15

Salbutamol Use in Ozone Air Pollution by People With Asthma and/or Exercise Induced Bronchoconstriction (EIB)NCT05087693 · 2021-11-01

Efficacy and Safety Study of Mepolizumab 100 Milligram (mg) Subcutaneous (SC) in Indian Participants Aged Greater Than or Equal to (>=) 18 Years With Severe Eosinophilic AsthmaNCT04276233 · 2021-06-29

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM) - Salbutamol vs Long-acting Muscarinic AntagonistsNCT05457868 · 2021-02-01

Effect of Fluticasone Furoate/Vilanterol on EIA in AdolescentsNCT04750603 · 2018-12-01

Phosphodiesterase 4 Gene Variant and Salbutamol Response in Persistent Childhood AsthmaNCT03592212 · 2018-11-23

Phase I Assessment of Hypertonic Saline in Moderate to Severe AsthmaticsNCT03556683 · 2018-10-01

A Safety and Efficacy Study of Mepolizumab in Subjects With Severe AsthmaNCT03562195 · 2018-08-29

Sensor and Electronic Health Records (EHR) Integration Pilot StudyNCT03357341 · 2018-07-23

Salbutamol Administration by Nebulizer Versus Metered Dose Inhaler With Spacer in Asthma in ChildrenNCT03816267 · 2018-05-15

A Clinical Study to Evaluate the Effect of the Connected Inhaler System (CIS) on Adherence to Maintenance Therapy in Poorly Controlled Asthmatic SubjectsNCT03380429 · 2018-01-31

A Long-term Safety Study of Fixed Dose Combination Therapy Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate in Japanese Subjects With AsthmaNCT03184987 · 2017-06-22

Status Asthmaticus on the PICU; Intravenous SalbutamolNCT03493503 · 2017-04-05

Evaluation of Aerosolized Drugs Deposition During Mechanical VentilationNCT02818270 · 2016-06-01

Efficacy of Intermittent Tiotropium in Early Childhood WheezingNCT03199976 · 2016-04-20

The Effects of RPL554 on Top of Standard COPD Reliever MedicationsNCT02542254 · 2015-10-01

Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With AsthmaNCT02502734 · 2015-09-07

A Multiple Dosing (14 Days) Study to Assess Efficacy and Safety of Three Dose Levels of AZD7594, Given Once Daily by Inhalation, in Patients With Mild to Moderate AsthmaNCT02479412 · 2015-06-25

A Study of the Efficacy and Safety of NVA237 in Patients With Moderate to Severe COPDNCT02371629 · 2015-06-24

Comparison of RPL554 With Placebo and Salbutamol in Asthmatic PatientsNCT02427165 · 2015-04-01

Efficacy of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)NCT01922271 · 2013-08-01

Beta Agonist Nebulization in Non Invasively Ventilated COPD Patients: Safety, and Therapeutic Efficacy Range.NCT01958814 · 2012-02-01

Use of Beta-agonists in Stable Severe Congestive Heart FailureNCT01447069 · 2011-10-01

A Chronic Obstructive Pulmonary Disease (COPD) Trial Investigating Roflumilast on Safety and Effectiveness in China, Hong Kong and Singapore:NCT01313494 · 2011-03-01

Helium-3 MRI Imaging Study in COPDNCT02207452 · 2010-08-05

Study on Foster Efficacy Maintenance and Reliever vs Foster Maintenance + Salbutamol Reliever in Asthmatics (MART2)NCT00861926 · 2009-03-20

Measurement of Respiratory Admittance for Pediatric Asthma DiagnosisNCT02877537 · 2008-10-01

Study to Assess the Effect of Salbutamol and Ipratropium Bromide in Chronic Obstructive Pulmonary Disease (COPD) PatientsNCT00911651 · 2008-06-01

A Comparative Study of Inhaled Ciclesonide Versus Placebo in Children (6-11 Years) With AsthmaNCT00384189 · 2006-09-01

Comparative Study on the Efficacy and Safety of Procaterol Versus Salbutamol Given Via Metered Dose Inhaler With Spacer in the Management of Acute Asthma Attack in the Emergency RoomNCT01091337 · 2006-05-01

Efficacy and Safety of Nebulised Beclomethasone Dipropionate Plus as Needed Salbutamol vs as Needed Salbutamol or as Needed Salbutamol/Beclomethasone Fixed Combination in Young Children With Asthma SymptomsNCT00497523 · 2006-03-01

Viapaed Study In Children And Adolescents With AsthmaNCT00315744 · 2004-11-04

Study to Assess the Efficacy of Ipratropium Bromide Associated With High Dose Salbutamol by Repeated Nebulisation Versus Repeat Nebulisation of Salbutamol Alone, in Acute Asthmatic Attacks in Young ChildrenNCT02235428 · 1998-09-01

Combivent vs. Salbutamol in Patients With Metacholine Induced BronchospasmNCT02182713 · 1998-05-01

Common conditions

Mapped diseases appearing in these trials

Shared study participation does not establish that this intervention treats a disease.

asthma18 chronic obstructive pulmonary disease9 bronchiolitis1 heart failure1

Leading sponsors

GlaxoSmithKline 8 AstraZeneca 4 Boehringer Ingelheim 2 Chiesi Farmaceutici S.p.A. 2 Novartis Pharmaceuticals 2 University of British Columbia 2 Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA 2 Assistance Publique - Hôpitaux de Paris 1 Brigham and Women's Hospital 1 Central Hospital, Nancy, France 1 Chang Gung University 1 Erasmus Medical Center 1 Hat Yai Medical Education Center 1 Helsinki University Central Hospital 1 Oman Medical Speciality Board 1

Trial status mix

COMPLETED30

UNKNOWN4

TERMINATED3

ACTIVE_NOT_RECRUITING1

RECRUITING1

Phase mix

PHASE415

PHASE39

NA5

PHASE25

EARLY_PHASE11

PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.